<i>GFAP</i> mutations, age at onset, and clinical subtypes in Alexander disease
Morgan J. Prust(Coriell Institute For Medical Research), Adeline Vanderver(Children's Hospital of Philadelphia), Michael Brenner(Michigan Medicine), Jon L. Fleming(Coriell Institute For Medical Research), Heidi A. Heilstedt(Coriell Institute For Medical Research), Deepak Gill(Children's Hospital at Westmead), Alyssa Reddy, T. Hartka(Coriell Institute For Medical Research), Hiroki Morizono(Coriell Institute For Medical Research), Martina Schneider(Valneva (Austria)), Jiaxian Wang(Coriell Institute For Medical Research), Martin Griebel(Coriell Institute For Medical Research), K Wakabayashi(Coriell Institute For Medical Research), Argirios Dinopoulos(Coriell Institute For Medical Research), Yoshihisa Takiyama(Coriell Institute For Medical Research), Edgar Gordon(Coriell Institute For Medical Research), Alexander Sokohl(Coriell Institute For Medical Research), Elliott H. Sherr(University of California, San Francisco), Albee Messing(University of Wisconsin–Madison), Heather Gordish‐Dressman(Coriell Institute For Medical Research), Maria Teresa Dotti(Coriell Institute For Medical Research), Daniel Fain(Coriell Institute For Medical Research), Yukio Sawaishi(Coriell Institute For Medical Research), M. Nakagawa(Coriell Institute For Medical Research), P A Kaplan(Coriell Institute For Medical Research), R.C. Pedersen(Coriell Institute For Medical Research), J. R. Gorospe(Coriell Institute For Medical Research), D. Lewis(Coriell Institute For Medical Research), Kathrin Brockman(Coriell Institute For Medical Research), Hernán Amartino(Manchester Royal Eye Hospital), J Ferreira(Coriell Institute For Medical Research), Raphael Schiffmann(Texas Christian University), Ricardo Suárez Fernández(Coriell Institute For Medical Research), Roger L. Albin(University of Michigan)
Cited by 256
Related Papers
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
|New England Journal of Medicine|2017|592
Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible
|Nature Genetics|2006|565
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study
|Nature Communications|2020|493